Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- CRCM +10.5%, PGTI +6.3%, BLMN +4.9%, ON +4.5%, FDC +4.3%, KBR +3.2%, CAT +3.2%, BAH +1.7%, STX +1.7%,ARLP +1.3%, SPG +0.8%
Other news:
- RDHL +30.6% (announces 'positive' top-line safety and efficacy results from the first Phase III study with RHB-104 for Crohn's disease)
- DRRX +15.6% (receives FDA approval for PERSERIS, the first once monthly subcutaneous risperidone-containing, long-acting injectable for the treatment of schizophrenia in adults)
- IBKR +4.1% (Interactive Brokers files for approx 1.5 share common stock offering by holders)
- DB +2.8% (FT details that Deutsche Bank (DB) might move some clearing staff to Frankfort Germany amid Brexit talks)
- PPDF +2.5% (enters agreement w/ Zhejiang University to develop an AI research and development center)
- UAA +1% (slightly rebounding following Friday's earnings)
- WMB +1% (enters into Denver-Julesburg Basin and Williams Partners (WPZ) exits from the Four Corners Area in New Mexico and Colorado)
- MRK +1% (confirms the EMA's CHMP adopted a positive opinion recommending approval of KEYTRUDA in combination with pemetrexed and platinum chemotherapy) .
Analyst comments:
- JNPR +1.6% (upgraded to Buy from Hold at Deutsche Bank)
- CAR +1.2% (upgraded to Buy from Neutral at Northcoast)
- T +1.1% (upgraded to Buy from Neutral at BofA/Merrill)
- COG +0.5% (upgraded to Positive from Neutral at Susquehanna)